ML MESOBLAST LTD Stock: price and insider trades · United States · SEC (Form 4)Track the MESOBLAST LTD stock price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 13 April 2026 (Acquisition). Among the most active insiders: George Gregory. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,414 of 29,064 companies
FCF yld -2.3%
Earn yld -4.6%
EV/EBITDA ·
ROE -18%
Gross mgn 70%
Net mgn ·
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 April 2026
All Executives30 Thresholds0 Prospectus0 Other0
Declarations 30 total
▲ Director · Executives · 9 Apr 2026
105,000 shares @ US$1.46 1.3% of flow Ordinary Shares SEC:0001999371-26-008132:2
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
500,000 shares @ US$1.44 6.3% of flow Ordinary Shares SEC:0001999371-26-008132:3
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
10,000 shares @ US$1.44 0.1% of flow Ordinary Shares SEC:0001999371-26-008132:4
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
20,000 shares @ US$1.43 0.2% of flow Ordinary Shares SEC:0001999371-26-008132:6
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
5,240 shares @ US$1.43 0.1% of flow Ordinary Shares SEC:0001999371-26-008132:8
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
5,000 shares @ US$1.43 0.1% of flow Ordinary Shares SEC:0001999371-26-008132:10
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
10,000 shares @ US$1.41 0.1% of flow Ordinary Shares SEC:0001999371-26-008132:13
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
4,760 shares @ US$1.44 0.1% of flow Ordinary Shares SEC:0001999371-26-008132:5
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
10,000 shares @ US$1.43 0.1% of flow Ordinary Shares SEC:0001999371-26-008132:7
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 4 Apr 2026
4,000,000 shares @ US$1.42 50.2% of flow Ordinary Shares SEC:0001999371-26-008132:0
Canonical exit: 3 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
886,890 shares @ US$1.43 11.1% of flow Ordinary Shares SEC:0001999371-26-008132:1
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
10,000 shares @ US$1.43 0.1% of flow Ordinary Shares SEC:0001999371-26-008132:9
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
10,000 shares @ US$1.43 0.1% of flow Ordinary Shares SEC:0001999371-26-008132:11
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
10,000 shares @ US$1.43 0.1% of flow Ordinary Shares SEC:0001999371-26-008132:12
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 10 Apr 2026
2,324,072 shares @ US$1.48 30.0% of flow Ordinary Shares SEC:0001999371-26-008132:14
Canonical exit: 9 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
886,890 shares @ US$1.43 3.4% of flow Ordinary Shares SEC:0001999371-26-008124:1
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
500,000 shares @ US$14.39 19.1% of flow Ordinary Shares SEC:0001999371-26-008124:2
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
10,000 shares @ US$14.40 0.4% of flow Ordinary Shares SEC:0001999371-26-008124:4
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
4,760 shares @ US$14.40 0.2% of flow Ordinary Shares SEC:0001999371-26-008124:5
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
10,000 shares @ US$14.30 0.4% of flow Ordinary Shares SEC:0001999371-26-008124:7
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
5,240 shares @ US$14.25 0.2% of flow Ordinary Shares SEC:0001999371-26-008124:8
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
10,000 shares @ US$14.25 0.4% of flow Ordinary Shares SEC:0001999371-26-008124:9
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 9 Apr 2026
5,000 shares @ US$14.30 0.2% of flow Ordinary Shares SEC:0001999371-26-008124:10
Canonical exit: 8 Jul 2026 (T+90) ▲ Director · Executives · 10 Apr 2026
2,324,072 shares @ US$1.48 9.1% of flow Ordinary Shares SEC:0001999371-26-008124:14
Canonical exit: 9 Jul 2026 (T+90) ▲ Director · Executives · 4 Apr 2026
4,000,000 shares @ US$1.42 15.3% of flow Ordinary Shares SEC:0001999371-26-008124:0
Canonical exit: 3 Jul 2026 (T+90) 25 of 30 declarations
Load more (5 remaining) 关于 MESOBLAST LTD MESOBLAST LTD 是一家生物制药公司，专注于开发用于治疗严重疾病的细胞疗法。该公司在纳斯达克上市，股票代码为 MSB。